IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDYM. S. Naumtseva, Yu. V. Muravyev, Г. М. Тарасова et al.|Rheumatology Science and Practice|2017Cited by 9
Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseasesД. В. Буханова, М. Е. Диатроптов, N. N. Yudkina et al.|Meditsinskiy sovet = Medical Council|2018Cited by 9